Stifel Financial
RANI icon

Stifel Financial’s Rani Therapeutics RANI Stock Holding History

Stifel Financial’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,684
Closed -$20.1K – 3516
2024
Q4 		$20.1K Sell
14,684
-255,084
-95% -$536K ﹤0.01% 3355
2024
Q3 		$583K Buy
269,768
+135,148
+100% +$387K ﹤0.01% 2576
2024
Q2 		$512K Buy
134,620
+2,186
+2% +$11.3K ﹤0.01% 2610
2024
Q1 		$412K Buy
132,434
+82,168
+163% +$283K ﹤0.01% 2725
2023
Q4 		$167K Sell
50,266
-91,638
-65% -$212K ﹤0.01% 3089
2023
Q3 		$309K Buy
141,904
+65,144
+85% +$249K ﹤0.01% 2776
2023
Q2 		$316K Buy
76,760
+41,243
+116% +$191K ﹤0.01% 2792
2023
Q1 		$183K Sell
35,517
-175
-0.5% -$1.05K ﹤0.01% 3070
2022
Q4 		$211K Sell
35,692
-5,003
-12% -$36.5K ﹤0.01% 2959
2022
Q3 		$390K Sell
40,695
-1,800
-4% -$19.1K ﹤0.01% 2580
2022
Q2 		$439K Buy
42,495
+595
+1% +$6.83K ﹤0.01% 2542
2022
Q1 		$566K Buy
41,900
+1,850
+5% +$30.7K ﹤0.01% 2510
2021
Q4 		$655K Buy
40,050
+2,100
+6% +$47.7K ﹤0.01% 2432
2021
Q3 		$676K Buy
+37,950
New +$656K ﹤0.01% 2392

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Stifel Financial's RANI Position: Q1 2025 in Review

Stifel Financial sold out of Rani Therapeutics (RANI) in Q1 2025, closing a stake of 14,684 shares — an estimated $20.1K sold.

Stifel Financial first reported a position in RANI in Q3 2021 and held it in 14 quarters. The position peaked at $676K in Q3 2021. 38 funds tracked by Wall St. Rank hold RANI as of Q1 2025.

  • Stifel Financial reported no remaining Rani Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Stifel Financial sold 14,684 Rani Therapeutics shares in Q1 2025, an estimated $20.1K.
  • Stifel Financial first reported a position in Rani Therapeutics in Q3 2021 and held it in 14 quarters.
  • Stifel Financial's Rani Therapeutics position peaked at $676K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2025.

Based on Stifel Financial's 13F filing for Q1 2025, filed 14 May 2025.